Andreas Wicki, Director at Pacira Pharmaceuticals, Inc. (PCRX), sold 10,956 shares at $49.83 ($546K) on 2018-11-12, disclosed to the SEC on 2018-11-14.
Open-market sale of $546k PCRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.83 | 5,478 | $273K | 50.0% |
| 2 | $49.83 | 5,478 | $273K | 50.0% |
| Total | $49.83 avg | 10,956 | $546K | 100% |
| Filing → |
| HRMY | SELL | 2022-11-16 | $6.1M | — | Filing → |
| HRMY | SELL | 2022-11-10 | $15.2M | — | Filing → |
| HRMY | SELL | 2022-11-04 | $68.2M | — | Filing → |